1181-Interferon-α Gene Therapy for Glioblastoma

Paper Talk · Jun 25, 2026 · 21m

This study details a phase 1 trial of Temferon, an innovative gene therapy designed to treat glioblastoma by utilizing genetically modified stem cells. The treatment engineers a patient's own cells to deliver interferon-α2 directly to the tumor microenvironment, effectively bypassing the toxicities associated with systemic administration. Researchers found the therapy to be safe and tolerable, with no dose-limiting toxicities observed across twenty-four subjects. Data indicates that Temferon successfully reprograms the immune environment, shifting suppressive macrophages into an inflammatory…